Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
History AOD-9604 was developed following research identifying the amino acid sequence 176-191 of human growth hormone as a region associated with specific metabolic activities
It carries two defining structural modifications: an N-terminal acetyl group and a bulky lipophilic C-terminal adamantane (diamondoid) group, the motif characteristic of Peptide 021
Led by Aloni Le, DNP, ARNP, FNP-C , a Board-Certified Nurse Practitioner with more than 13 years of advanced medical experience, our treatments are carefully designed to deliver what your body needs safely and effectively
For those with irreversible causes such as pernicious anaemia or malabsorption, injections are usually given every 23 months
This gives you concrete evidence to take to your GP or a private clinician, ensuring you can have a productive conversation and get the right treatment without any needless delays
